在患有慢性阻塞性肺病的患者中,身体组成和疾病严重程度之间的相关性
Xiaohan Jin1,2, Yu Yang1, Guangmei Chen1,3
1Department of Respiratory Medicine, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Frontiers in medicine
|March 29, 2024
概括
身体组成的变化显著影响慢性阻塞性肺病 (COPD) 患者,与疾病严重程度相关. 这些发现强调了在COPD管理中评估身体成分的重要性.
科学领域:
- 肺部医学 肺部医学
- 临床营养学 临床营养学
- 生物医学工程 生物医学工程
背景情况:
- 身体组成的改变是慢性阻塞性肺病 (COPD) 中显著的肺外表现.
- 了解这些变化对于管理COPD患者至关重要.
- 这项研究研究了人体组成特征及其与COPD严重程度的关系.
研究的目的:
- 为了描述COPD患者的身体组成.
- 探索身体组成和COPD疾病严重程度之间的相关性.
- 为了确定疾病进展的潜在生物标志物.
主要方法:
- 纳入了105名COPD患者和105名对照人群.
- 使用生物电阻分析 (BIA) 评估身体成分.
- 根据GOLD指南对COPD的严重程度进行了分类,包括FEV1%pred,mMRC,CAT得分和恶化风险.
主要成果:
- 与对照组相比,COPD患者的BMI,FFMI和PhA较低,ECW/TBW和ECW/ICW比率较高 (p <0.05).与对照组相比,COPD患者的BMI,FFMI和PhA较低,ECW/TBW和ECW/ICW比率较高.
- 随着疾病的严重程度,身体组成有显著的变化;FFMI和PhA下降,而ECW/TBW和ECW/ICW随着COPD恶化而增加.
- FFMI和PhA显示了与mMRC和CAT得分的负相关性,以及与FEV1%前期的正相关性.
结论:
- 在COPD患者和对照人群之间,身体组成存在显著差异.
- 身体成分与COPD严重程度密切相关,在不同疾病阶段观察到不同的模式.
- 这些发现强调了身体成分评估在COPD管理中的临床相关性.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


